Literature DB >> 2982164

Purification and characterization of the mu opiate receptor from rat brain using affinity chromatography.

R Maneckjee, R S Zukin, S Archer, J Michael, P Osei-Gyimah.   

Abstract

Opiate receptors have been solubilized from rat neural membranes and purified 500-fold (relative to the crude solubilized extract) by affinity chromatography. Active receptors were solubilized by using 3-[( 3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), a zwitterionic derivative of cholic acid. Affinity chromatography was carried out using Affi-Gel 401, a sulfhydryl derivative of agarose to which "hybromet," a newly synthesized opioid ligand with high affinity for the mu receptor, had been attached. Scatchard analysis of [3H]etorphine binding to the purified receptor revealed a single class of high-affinity sites (Kd = 1.4 nM; Bmax = 2800 fmol/mg of protein). Half-maximal binding was achieved at approximately equal to 1 nM. Activity was markedly inhibited by protein modifying reagents, findings which suggest that the sites are proteinaceous. Opiate binding activity was also inhibited by the guanyl nucleotide GTP. Electrophoresis of the purified material under denaturing conditions revealed three subunits of molecular weights 94,000, 44,000, and 35,000. The inhibitory guanyl nucleotide binding protein (Ni) implicated in opiate action has been shown to be comprised of two subunits of molecular weights 42,000 and 35,000. Thus, the opiate receptor may be an aggregate of multiple protein components that may include a guanyl nucleotide binding protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982164      PMCID: PMC397087          DOI: 10.1073/pnas.82.2.594

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Novel analgesics and molecular rearrangements in the morphine-thebaine group. II. Alcohols derived from 6,14-endo-etheno- and 6,14-endo-ethanotetrahydrothebaine.

Authors:  K W Bentley; D G Hardy; B Meek
Journal:  J Am Chem Soc       Date:  1967-06-21       Impact factor: 15.419

2.  Phospholipase A inhibition of opiate receptor binding can be reversed by albumin.

Authors:  H K Lin; E J Simon
Journal:  Nature       Date:  1978-01-26       Impact factor: 49.962

3.  Solubilized tetrodotoxin binding component from the electroplax of Electrophorus electricus. Stability as a function of mixed lipid-detergent micelle composition.

Authors:  W S Agnew; M A Raftery
Journal:  Biochemistry       Date:  1979-05-15       Impact factor: 3.162

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Multiple opiate receptors: emerging concepts.

Authors:  R S Zukin; S R Zukin
Journal:  Life Sci       Date:  1981-12-28       Impact factor: 5.037

6.  Identification of a Mr 58 000 glycoprotein subunit of the opiate receptor.

Authors:  W A Klee; W F Simonds; F W Sweat; T R Burke; A E Jacobson; K C Rice
Journal:  FEBS Lett       Date:  1982-12-13       Impact factor: 4.124

7.  Chemical crosslinking of a solubilized enkephalin macromolecular complex.

Authors:  R S Zukin; R M Kream
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Identification of the predominant substrate for ADP-ribosylation by islet activating protein.

Authors:  G M Bokoch; T Katada; J K Northup; E L Hewlett; A G Gilman
Journal:  J Biol Chem       Date:  1983-02-25       Impact factor: 5.157

9.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

10.  Solubilization and characterization of active opiate binding sites from mammalian brain.

Authors:  R D Howells; T L Gioannini; J M Hiller; E J Simon
Journal:  J Pharmacol Exp Ther       Date:  1982-09       Impact factor: 4.030

View more
  9 in total

Review 1.  The molecular structure of opiate receptors.

Authors:  M Wollemann
Journal:  Neurochem Res       Date:  1987-02       Impact factor: 3.996

Review 2.  The next frontier in the molecular biology of the opioid system. The opioid receptors.

Authors:  O Civelli; C Machida; J Bunzow; P Albert; E Hanneman; J Salon; J Bidlack; D Grandy
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

3.  Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated mu- and delta-opioid receptors.

Authors:  A N Schoffelmeer; F Hogenboom; A H Mulder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

4.  Preparation of [125I-Tyr27,Leu5]beta h-endorphin and its use for crosslinking of opioid binding sites in human striatum and NG108-15 neuroblastoma-glioma cells.

Authors:  D M Helmeste; R G Hammonds; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Purification to apparent homogeneity of a mu-type opioid receptor from rat brain.

Authors:  T M Cho; J Hasegawa; B L Ge; H H Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Morphine enhances the phosphorylation of a 58 kDa protein in mouse brain membranes.

Authors:  K Nagamatsu; K Suzuki; R Teshima; H Ikebuchi; T Terao
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

7.  Opioid-binding protein (OBCAM) is rich in beta-sheets.

Authors:  C S Wu; J Hasegawa; A P Smith; H H Loh; N M Lee; J T Yang
Journal:  J Protein Chem       Date:  1990-02

8.  Purification of the opiate receptor of NG108-15 neuroblastoma-glioma hybrid cells.

Authors:  W F Simonds; T R Burke; K C Rice; A E Jacobson; W A Klee
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

9.  Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact.

Authors:  P R Schofield; K C McFarland; J S Hayflick; J N Wilcox; T M Cho; S Roy; N M Lee; H H Loh; P H Seeburg
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.